Cargando…
The Xpert(®) MTB/RIF diagnostic test for pulmonary and extrapulmonary tuberculosis in immunocompetent and immunocompromised patients: Benefits and experiences over 2 years in different clinical contexts
Xpert(®) MTB/RIF has been widely used for tuberculosis (TB) diagnosis in Brazil, since 2014. This prospective observational study aimed to evaluate the performance of Xpert in different contexts during a two-year period: (i) laboratory and clinical/epidemiological diagnosis; (ii) HIV-positive and -n...
Autores principales: | Tomaz, Ana Paula de Oliveira, Raboni, Sonia Mara, Kussen, Gislene Maria Botão, da Silva Nogueira, Keite, Lopes Ribeiro, Clea Elisa, Costa, Libera Maria Dalla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928506/ https://www.ncbi.nlm.nih.gov/pubmed/33657113 http://dx.doi.org/10.1371/journal.pone.0247185 |
Ejemplares similares
-
Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021) -
Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018) -
Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil
por: Kussen, Gislene Maria Botão, et al.
Publicado: (2015) -
The use of Gene-Xpert MTB RIF in the diagnosis of extrapulmonary
tuberculosis in childhood and adolescence
por: Aurilio, Rafaela Baroni, et al.
Publicado: (2020) -
Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis
por: Mechal, Youness, et al.
Publicado: (2019)